Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Artro-Activ MSM is a dietary supplement developed by the Russian company Diod, specifically formulated to support joint health and manage musculoskeletal disorders. It contains a combination of glucosamine (1020 mg), chondroitin sulfate (810 mg), and methylsulfonylmethane (MSM, 600 mg) per daily dose. Glucosamine and chondroitin are essential structural components of cartilage tissue, promoting its regeneration and resilience. MSM serves as a source of organic sulfur, providing anti-inflammatory effects and strengthening connective tissues, including ligaments and joints. The supplement is recommended for individuals with high physical activity, excess weight, or age-related joint changes, and as an adjunct for conditions like osteoarthritis and osteochondrosis.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Artro-Activ MSM.